Influence of esmolol on plasma NT-proBNP, heart-type fatty acid binding protein and cardiac function in acute cerebral infarction patients with myocardial enzyme abnormalities
- VernacularTitle:盐酸艾司洛尔对伴有心肌酶异常的急性脑梗死患者血浆NT－proBNP、心型脂肪酸结合蛋白及心功能的影响
- Author:
Hongyan WANG
;
Zhigang LUO
;
Jiaheng XU
;
Xiaobin LI
;
Lili XIE
;
Yanlan LI
- Publication Type:Journal Article
- Keywords:
esmolol hydrochloride;
acute myocardial infarction;
NT-proBNP;
H-FABP;
cardiac function
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(3):138-140
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse the influence of esmolol on plasma N terminal pro-brain natriuretic peptide ( NT-proBNP) , heart-type fatty acid binding protein ( H-FABP) and cardiac function in acute cerebral infarction patients with myocardial enzyme abnormalities.Methods 86 acute cerebral infarction patients with myocardial enzyme abnormalities from September 2010 to July 2014 in our hospital were selected and divided into experimental group and control group randomly (43 cases in each group).All patients were accompanied by myocardial enzyme abnormalities, patients in control group were given basic treatment, while patients in experimental group were given esmolol hydrochloride intravenous injection on the basis of control group.Plasma NT-proBNP, H-FABP levels and cardiac function were analyzed in two groups.Results Myocardial enzyme levels had no significant difference between two groups on admission.Plasma NT-proBNP levels also had no statistical differences after admission hospital of 6 h, 15 h and 3 d , and experimental group was significantly lower than control group ( P<0.05 ) after admission hospital of 5 day and 7 days.H-FABP levels had no statistical differences after admission hospital of 6 h, 15 h, and the experimental group was significantly lower than the control group (P<0.05) after admission hospital of 3, 5, 7 days.Cardiac function with Killip classification showed no significant difference when on admission and after admission hospital of 3 days, and the experimental group was significantly better than control group (P<0.05) after admission hospital of 5, 7 days.Conclusion Acute cerebral infarction patients with myocardial enzyme abnormalities given esmolol on the basic treatments significantly reduce NT-proBNP and HAFBP levels, and improve cardiac function, which is worthy of promotion in clinical applications.
